Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
- PMID: 40812312
- DOI: 10.1016/j.molcel.2025.08.011
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Erratum for
-
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.Mol Cell. 2018 Jan 18;69(2):279-291.e5. doi: 10.1016/j.molcel.2017.12.024. Mol Cell. 2018. PMID: 29351847 Free PMC article.
Similar articles
-
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.Mol Cell. 2018 Jan 18;69(2):279-291.e5. doi: 10.1016/j.molcel.2017.12.024. Mol Cell. 2018. PMID: 29351847 Free PMC article.
-
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.Mol Cell. 2025 Aug 7;85(15):3002. doi: 10.1016/j.molcel.2025.07.011. Epub 2025 Jul 23. Mol Cell. 2025. PMID: 40706598 No abstract available.
-
PQQ Inhibits PRC2 Methyltransferase Activity and Suppresses the Proliferation of B-Cell Lymphoma In Vitro.Chem Biodivers. 2025 Jul;22(7):e202500198. doi: 10.1002/cbdv.202500198. Epub 2025 Mar 23. Chem Biodivers. 2025. PMID: 40024903
-
The dual functionality of EZH2 in cardiovascular disease: Bridging cancer biology and cardiac pathophysiology through epigenetic regulation, metabolic reprogramming, and novel therapeutic interventions.Curr Probl Cardiol. 2025 Sep;50(9):103104. doi: 10.1016/j.cpcardiol.2025.103104. Epub 2025 Jun 13. Curr Probl Cardiol. 2025. PMID: 40517834 Review.
-
EZH2 in digestive system cancers: Epigenetic regulation, oncogenic interactions, and therapeutic potential.Exp Cell Res. 2025 Jul 15;450(2):114648. doi: 10.1016/j.yexcr.2025.114648. Epub 2025 Jun 10. Exp Cell Res. 2025. PMID: 40499609 Review.
Publication types
LinkOut - more resources
Full Text Sources